Methyl 4-hydroxypyrimidine-5-carboxylate

Catalog No.: 
ACMJKT025
CAS No.: 
4774-35-0
Molecular Formula: 
C6H6N2O3
Molecular Weight: 
154.13
Methyl 4-hydroxypyrimidine-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g96%$70.00In stockInquiry
100g96%$276.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-hydroxypyrimidine-5-carboxylate
IUPAC Namemethyl 4-hydroxypyrimidine-5-carboxylate
MDL No.MFCD01632117
Molecular FormulaC6H6N2O3
Molecular Weight154.13
SMILESCOC(=O)C1=CN=CN=C1O
InChI KeyKFWOVXLWAGKILN-UHFFFAOYSA-N
SynonymA7300 | KBio3_000867 | methyl 4-hydroxypyrimidine-5-carboxylate | 4-Hydroxy-pyrimidine-5-carboxylic acid methyl ester | 4-Hydroxypyrimidine-5-carboxylic acid methyl ester | SY018263 | Tox21_200073 | AC-2412 | BB 0238900 | KFWOVXLWAGKILN-UHFFFAOYSA-N | met
CAS No.4774-35-0
PubChem CID11744833

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMJKT025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACTPMA398 route compound structure diagram
    ACTPMA39865754-04-3In Stock
  4. Then
  5. ACMJKT025 route product structure diagram
    ACMJKT0254774-35-0In Stock
Inquiry

2. ACMJKT025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMJKT025 route product structure diagram
    ACMJKT0254774-35-0In Stock
Inquiry

3. ACMJKT025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMJKT025 route product structure diagram
    ACMJKT0254774-35-0In Stock
Inquiry

Comments (0)